| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |